Table:
begin	end	state
1	24	cytoplasmic
25	48	transmembrane
49	53	non-cytoplasmic
54	76	transmembrane
77	84	cytoplasmic
85	110	transmembrane
111	121	non-cytoplasmic
122	143	transmembrane
144	149	cytoplasmic
150	172	transmembrane
173	178	non-cytoplasmic
179	206	transmembrane
207	213	cytoplasmic
214	238	transmembrane
239	271	cytoplasmic
272	294	transmembrane
295	297	non-cytoplasmic
298	318	transmembrane
319	328	cytoplasmic
329	352	transmembrane
353	358	non-cytoplasmic
359	359	cytoplasmic
360	383	transmembrane
384	394	cytoplasmic
395	411	transmembrane
412	412	cytoplasmic
413	422	non-cytoplasmic
423	425	cytoplasmic
426	446	transmembrane
447	447	cytoplasmic

Input:
>AO353_24495
MNKSYEQSLKIDAPRDGRLRQLRSLCGYEIGVIPLPIFLGIAVIVYLSAHLGFLPNNMIG
GLAVIMTMGMFFGQLGSRLPILKEIGGGAILCLMLPSILVFYGFFGPATIDATKMLMKEA
NFLYFVIASLVVGSILGMSRFILIQGMMRMFIPLLVGTLAAVASGLIVGKLVGYSFYHTF
FFIIVPIIGGGIGEGILPLSLAYSAILGGTPDIYVAKLVPAAVVGNIAAIICAGYLARLA
LKRPHLNGEGSLIRAKDENDKFQAREDNGSTIDFRVIGAGILVICAFFVLGGLLEKILGV
PGPVLMILAAVLFKYIRVLPEKLEKGTNAFYKLISSAFIWPVMIGLGMLYVPLDSVVKVF
SISYVLVCVSVVASMAIAGFFIGNLMKMYPIESAIVTCCHSGLGGTGDVAILSASNRMSL
MPFAQISTRLGGASTVIIASILLRIFA

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server